Drug intelligence / Profile preview

Lingzhu Tusizi Pill

Development stage: Preclinical
Lead developer: Hospital of Traditional Chinese Medicine Affiliated to Southwest Medical University
Administration: Oral

Overview

Lingzhu Tusizi Pill is a traditional Chinese medicine formulated as a pill, currently undergoing clinical trials for the treatment of renal albuminuria. It is a combination of various herbal ingredients, including Fuling (Poria), Baizhu (Atractylodes macrocephala), and Tusizi (Dodder Seed), which are traditionally known for their kidney-tonifying and spleen-strengthening properties.

Other names: lingzhu tusizi加减苓术菟丝子丸

Targets

SYK (Spleen Tyrosine Kinase)

Beyond the preview

Go deeper on Lingzhu Tusizi Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lingzhu Tusizi Pill.

Explore the full profile